-
BrainStorm Cell Therapeutics – NUROWN
It’s stock crashed today. Down 67%. Reason: release of negative top-line results from a phase 3 clinical trial for its leading candidate treatment. NurOwn failed to achieve statistically significant efficacy results.
Read this short article and see what you think about the whole affair. Just know they have been working on this for 10+ years!
https://www.nasdaq.com/articles/why-brainstorm-cell-therapeutics-stock-imploded-today-2020-11-17
Sorry, there were no replies found.
Log in to reply.